COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 1748: Articles 17471-17480  | Next

Comparative studies of the seven human coronavirus envelope proteins using topology prediction and molecular modelling to understand their pathogenicity
Schoeman, D., Cloete, R., Fielding, B.
10.1101/2021.03.08.434384 — Posted: 2021-03-08
Comparative host interactomes of the SARS-CoV-2 nonstructural protein 3 and human coronavirus homologs
Almasy, K. M., Davies, J. P., Plate, L.
10.1101/2021.03.08.434440 — Posted: 2021-03-08
Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2
Nguyen, L., McCord, K. A., Bui, D. T., Bouwman, K. A., Kitova, E. N., Kumawat, D., Daskan, G. C., Tomris, I., Han, L., Chopra, P., Yang, T.-J., Williows, S. D., Lowary, T. L., West, L. J., Hsu, S.-T. D., Tompkins, S. M., Boons, G.-J., Mason, A. L., de Vries, R. P., Macauley, M. S., Klassen, J. S.
10.1101/2021.03.08.434228 — Posted: 2021-03-08
SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection
Bashor, L., Gagne, R. B., Bosco-Lauth, A., Bowen, R., Stenglein, M., VandeWoude, S.
10.1101/2021.03.05.434135 — Posted: 2021-03-08
Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract
Alfi, O., Yakirevich, A., Wald, O., Wandel, O., Izhar, U., Oiknine-Djian, E., Nevo, Y., Elgavish, S., Dagan, E., Madgar, O., Feinmesser, G., Pikarsky, E., Bronstein, M., Vorontsov, O., Jonas, W., Ives, J., Walter, J., Zakay-Rones, Z., Oberbaum, M., Panet, A., Wolf, D. G.
10.1101/2021.03.08.434404 — Posted: 2021-03-08
A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic
Pollett, S., Conte, M. A., Sanborn, M. A., Jarman, R. G., Lidl, G. M., Modjarrad, K., Maljkovic Berry, I.
10.1101/2021.03.07.434287 — Posted: 2021-03-08
Experimental susceptibility of North American raccoons (Procyon lotor) and striped skunks (Mephitis mephitis) to SARS-CoV-2
Francisco, R., Hernandez, S. M., Mead, D. G., Adcock, K. G., Burke, S. C., Nemeth, N. M., Yabsley, M. J.
10.1101/2021.03.06.434226 — Posted: 2021-03-08
Pediatric nasal epithelial cells are less permissive to SARS-CoV-2 replication compared to adult cells
Zhu, Y., Chew, K. Y., Karawita, A. C., Yamamoto, A., Labzin, L. L., Yarlagadda, T., Khromykh, A. A., Stocks, C. J., Xia, Y., Kollmann, T. R., Martino, D., Kicic, A., Bielefeldt-Ohmann, H., Bowen, A. C., Sly, P. D., Spann, K. M., Short, K. R.
10.1101/2021.03.08.434300 — Posted: 2021-03-08 Discussion: Onsite
Drug development of an affinity enhanced, broadly neutralizing heavy chain only antibody that restricts SARS-CoV-2 in hamsters
Schepens, B., van Schie, L., Nerinckx, W., Roose, K., Van Breedam, W., Fijalkowska, D., Devos, S., Weyts, W., De Cae, S., Vanmarcke, S., Lonigro, C., Eeckhaut, H., Van Herpe, D., Borloo, J., Oliveira, A. F., Catani, J. P., Creytens, S., De Vlieger, D., Michielsen, G., Marchan, J. C. Z., Moschonas, G. D., Rossey, I., Sedeyn, K., Van Hecke, A., Zhang, X., Langendries, L., Jacobs, S., ter Horst, S., Seldeslachts, L., Liesenborghs, L., Boudewijns, R., Tibaut, H. J., Dallmeier, K., Vande Velde, G., Weynand, B., Beer, J., Schnepf, D., Ohnemus, A., Foo, C. S.-Y., Abdelnabi, R., Maes, P., Kaptein, S. J. F., Rochapereira, J., Jochmans, D., Delang, L., Peelman, F., Staeheli, P., Schwemmle, M., Tersago, D., Germano, M., Heads, J., Henry, A., Popplewell, A., Ellis, M., Brady, K., Turner, A., Dombrecht, B., Stortelers, C., Neyts, J., Callewaert, N., Saelens, X.
10.1101/2021.03.08.433449 — Posted: 2021-03-08
Deletion disrupts a conserved antibody epitope in a SARS-CoV-2 variant of concern
Rennick, L. L., Robinson-McCarthy, L. R., Nambulli, S., Duprex, W. P., McCarthy, K. R.
10.1101/2021.03.05.434168 — Posted: 2021-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).